Clinical Trials Browser

Phase 1/2 × Glioblastoma × Verteporfin × Clear all

NCT04590664 2025-02-25

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

Phase 1/2 Recruiting

Glioblastoma